Search details
1.
Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
Prostate
; 82(7): 858-866, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35286730
2.
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.
Cancer
; 127(16): 2954-2965, 2021 08 15.
Article
in English
| MEDLINE | ID: mdl-33951180
3.
Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial.
Prostate
; 77(4): 385-395, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27862097
4.
Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting.
Sarcoma
; 2012: 406239, 2012.
Article
in English
| MEDLINE | ID: mdl-22619564
5.
Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer.
Eur J Cancer
; 81: 228-236, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28502694
6.
Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma.
Clin Cancer Res
; 21(21): 4868-80, 2015 Nov 01.
Article
in English
| MEDLINE | ID: mdl-26071485
7.
Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression.
J Clin Invest
; 124(1): 285-96, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24334454
Results
1 -
7
de 7
1
Next >
>>